571 related articles for article (PubMed ID: 32965654)
41. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
McPartlin SO; Morrison J; Rohrig A; Weijer C
BMJ; 2020 Nov; 371():m4258. PubMed ID: 33168564
[No Abstract] [Full Text] [Related]
42. Rational Vaccine Design in the Time of COVID-19.
Burton DR; Walker LM
Cell Host Microbe; 2020 May; 27(5):695-698. PubMed ID: 32407707
[TBL] [Abstract][Full Text] [Related]
43. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
Moise L; Ross TM; Hoft DF; Martin WD; De Groot AS
Expert Rev Vaccines; 2020 Sep; 19(9):781-784. PubMed ID: 32962468
[No Abstract] [Full Text] [Related]
44. Audio Interview: New SARS-CoV-2 Vaccine Results, with Peter Piot.
Rubin EJ; Baden LR; Piot P; Morrissey S
N Engl J Med; 2020 Jul; 383(5):e57. PubMed ID: 32726549
[No Abstract] [Full Text] [Related]
45. A timely update of global COVID-19 vaccine development.
Klavinskis LS; Liu MA; Lu S
Emerg Microbes Infect; 2020 Dec; 9(1):2379-2380. PubMed ID: 33059515
[TBL] [Abstract][Full Text] [Related]
46. Russian SARS-CoV-2 vaccine.
Caddy S
BMJ; 2020 Aug; 370():m3270. PubMed ID: 32839191
[No Abstract] [Full Text] [Related]
47. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
48. Status of COVID-19 vaccine development.
Taxt AM; Grødeland G; Lind A; Müller F
Tidsskr Nor Laegeforen; 2020 Sep; 140(13):. PubMed ID: 32998488
[TBL] [Abstract][Full Text] [Related]
49. What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist.
Palatnik-de-Sousa CB
Front Immunol; 2020; 11():2173. PubMed ID: 32983183
[No Abstract] [Full Text] [Related]
50. The Race to Develop a COVID-19 Vaccine.
Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
[TBL] [Abstract][Full Text] [Related]
51. Tracking a Vaccine and Developing Therapeutics for COVID-19.
Gould KA
Dimens Crit Care Nurs; 2020; 39(6):293-297. PubMed ID: 33009266
[No Abstract] [Full Text] [Related]
52. [Societal impact of vaccination : beyond individual protection. Renewed interest following COVID-19 pandemic ?].
Dauby N
Rev Med Liege; 2020 Sup; 75(S1):170-175. PubMed ID: 33211442
[TBL] [Abstract][Full Text] [Related]
53. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay.
Wong LP; Alias H; Wong PF; Lee HY; AbuBakar S
Hum Vaccin Immunother; 2020 Sep; 16(9):2204-2214. PubMed ID: 32730103
[TBL] [Abstract][Full Text] [Related]
54. Towards intervention development to increase the uptake of COVID-19 vaccination among those at high risk: Outlining evidence-based and theoretically informed future intervention content.
Williams L; Gallant AJ; Rasmussen S; Brown Nicholls LA; Cogan N; Deakin K; Young D; Flowers P
Br J Health Psychol; 2020 Nov; 25(4):1039-1054. PubMed ID: 32889759
[TBL] [Abstract][Full Text] [Related]
55. Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries.
Cambon L; Schwarzinger M; Alla F
Vaccine; 2022 Jan; 40(2):178-182. PubMed ID: 34863619
[TBL] [Abstract][Full Text] [Related]
56. COVID-19 Vaccine Hesitancy in Canada: Content Analysis of Tweets Using the Theoretical Domains Framework.
Griffith J; Marani H; Monkman H
J Med Internet Res; 2021 Apr; 23(4):e26874. PubMed ID: 33769946
[TBL] [Abstract][Full Text] [Related]
57. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
[TBL] [Abstract][Full Text] [Related]
58. Individual preferences for COVID-19 vaccination in China.
Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
[TBL] [Abstract][Full Text] [Related]
59. Practical approaches to vaccine hesitancy issues in the United States: 2013.
Domachowske JB; Suryadevara M
Hum Vaccin Immunother; 2013 Dec; 9(12):2654-7. PubMed ID: 24126048
[TBL] [Abstract][Full Text] [Related]
60. Pediatric health care professionals' vaccine knowledge, awareness and attitude: a survey within the Italian Society of Pediatric Allergy and Immunology.
Del Duca E; Chini L; Graziani S; Sgrulletti M; Moschese V;
Ital J Pediatr; 2021 Sep; 47(1):183. PubMed ID: 34503574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
